Showing results (121-130 of 148) with videos related to

Sort By:
Pageof 15
JACC. Cardiovascular Imaging|May 21, 2018
Proposed Stages of Myocardial Phenotype Development in Fabry DiseaseSabrina Nordin, Rebecca Kozor, Katia Medina-Menacho, et al.
British Journal of Cancer|May 22, 2020
Fatigue, quality of life and physical fitness following an exercise intervention in multiple myeloma survivors (MASCOT): an exploratory randomised Phase 2 trial utilising a modified Zelen designDimitrios A Koutoukidis, Joanne Land, Allan Hackshaw, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|May 17, 2021
Pleural space management after lung transplant: Early and late outcomes of pleural decorticationJesse M Rappaport, Hafiz U Siddiqui, Andrew Tang, et al.
Nature Chemical Biology|November 6, 2007
Catalytic generation of N2O3 by the concerted nitrite reductase and anhydrase activity of hemoglobinSwati Basu, Rozalina Grubina, Jinming Huang, et al.
Plos One|March 9, 2013
Migalastat HCl reduces globotriaosylsphingosine (lyso-Gb3) in Fabry transgenic mice and in the plasma of Fabry patientsBrandy Young-Gqamana, Nastry Brignol, Hui-Hwa Chang, et al.
Orphanet Journal of Rare Diseases|October 15, 2021
In-depth phenotyping for clinical stratification of Gaucher diseaseSimona D'Amore, Kathleen Page, Aimée Donald, et al.
American Journal of Hematology|August 2, 2017
Outcomes after 18 months of eliglustat therapy in treatment-naïve adults with Gaucher disease type 1: The phase 3 ENGAGE trialPramod K Mistry, Elena Lukina, Hadhami Ben Turkia, et al.
American Journal of Hematology|February 13, 2013
Velaglucerase alfa enzyme replacement therapy compared with imiglucerase in patients with Gaucher diseaseHadhami Ben Turkia, Derlis E Gonzalez, Norman W Barton, et al.
Journal of Medical Genetics|February 14, 2018
Agalsidase alfa versus agalsidase beta for the treatment of Fabry disease: an international cohort studyMaarten Arends, Marieke Biegstraaten, Christoph Wanner, et al.
Circulation. Cardiovascular Imaging|April 9, 2013
Identification and assessment of Anderson-Fabry disease by cardiovascular magnetic resonance noncontrast myocardial T1 mappingDaniel M Sado, Steven K White, Stefan K Piechnik, et al.
Pageof 15